AMPH icon

Amphastar Pharmaceuticals

213 hedge funds and large institutions have $764M invested in Amphastar Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 71 increasing their positions, 83 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less ownership

Funds ownership:

9% less capital invested

Capital invested by funds: $839M → $764M (-$74.8M)

14% less repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 83

Holders
213
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.34M
Puts
$316K
Net Calls
Net Calls Change

Top Buyers

1 +$6.47M
2 +$2.6M
3 +$2.34M
4
First Trust Advisors
First Trust Advisors
Illinois
+$1.82M
5
Invesco
Invesco
Georgia
+$1.63M

Top Sellers

1 -$6.03M
2 -$4.91M
3 -$3.72M
4
Allspring Global Investments
Allspring Global Investments
North Carolina
-$3.25M
5
BlackRock
BlackRock
New York
-$3.06M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$317K
127
$315K
128
$312K
129
$310K
130
$308K
131
$305K
132
$300K
133
$297K
134
$294K
135
$289K
136
$287K
137
$282K
138
$281K
139
$280K
140
$269K
141
$268K
142
$259K
143
$244K
144
$242K
145
$237K
146
$231K
147
$220K
148
$219K
149
$216K
150
$213K